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Purpose: To evaluate the roles of CCL3 and its specific chemokine receptors, CCR1 and CCR5, in alkali-induced corneal
neovascularization (CNV).
Methods: Chemical denudation of corneal and limbal epithelium was performed on wild-type (WT) BALB/c mice and
CCL3-, CCR1-, and CCR5-deficienct (knockout [KO]) counterparts. Two weeks after injury CNV was quantified by
immunostaining with anti-CD31. Angiogenic factor expression and leukocyte accumulation in the early phase after injury
were quantified by reverse transcription polymerase chain reaction (RT–PCR) and immunohistochemical analysis,
respectively.
Results: Alkali injury augmented the intraocular mRNA expression of CCL3 and its receptors, CCR1 and CCR5, together
with a transient infiltration of F4/80 positive macrophages and Gr-1 positive neutrophils. Compared with WT mice, CCL3-
KO and CCR5-KO mice but not CCR1-KO mice exhibited reduced CNV two weeks after injury both macroscopically
and microscopically as evidenced by CD31 positive areas. Concomitantly, the infiltration of F4/80 positive macrophages
but not Gr-1 positive neutrophils was significantly attenuated in CCL3-KO mice compared with WT mice. Intracorneal
infiltration of CCR5 expressing cells was significantly impaired in CCL3-KO mice compared with WT mice. Alkali injury
induced a massive increase in the intraocular mRNA expression of a potent angiogenic factor, vascular endothelial growth
factor (VEGF), in WT mice whereas these increments were severely retarded in CCL3-KO mice. Moreover, CCL3
enhanced VEGF expression by murine peritoneal macrophages at both the mRNA and the protein level. Furthermore,
topical CCL3 application restored CNV, which was macroscopically and microscopically reduced in CCL3-KO mice after
two weeks to levels similar to those found in WT mice.
Conclusions: In alkali-induced CNV, CCL3 induced macrophages to infiltrate and produce VEGF by binding to CCR5
but not to CCR1 and eventually promoted angiogenesis.
The  cornea  is  characterized  by  an  absence  of  blood
vessels under physiologic conditions [1]. Corneal avascularity
is  maintained  by  a  balance  between  angiogenic  and  anti-
angiogenic molecules [2-6] and is required for optical clarity
and  the  maintenance  of  vision.  Thus,  corneal
neovascularization (CNV) can lead to impaired vision when
it arises from any cause including corneal infections, misuse
of contact lenses, chemical burns, and inflammation [7-9]. In
most  of  these  conditions,  a  large  number  of  neutrophils
infiltrate into the cornea before the onset of CNV followed by
an  infiltration  of  monocytes/macrophages.  Although
neutrophils are presumed to be involved in CNV, we have
previously  shown  that  alkali-induced  CNV  developed
independently of granulocyte infiltration [10].
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Leukocyte  infiltration  is  regulated  by  coordinative
actions  of  adhesion  molecules  and  chemokines  with  the
chemokine  receptor  expression  pattern  on  leukocytes
determining their responsiveness to a given chemokine [11].
Monocytes/macrophages express a distinct set of chemokine
receptors including CCR1, CCR2, CCR5, and CX3CR1 on
their cell surface [12-14]. We have previously found a potent
angiogenic  factor,  vascular  endothelial  growth  factor
(VEGF),  which  was  detected  in  intraocularly  infiltrating
monocytes/macrophages  before  CNV  development  [10].
CNV could be consistently attenuated by genetic ablation of
either the CCR2 or CCR5 gene [15,16], which also reduced
intraocular  VEGF  production.  In  contrast,  several  other
groups have provided evidence to indicate that infiltrating
macrophages  have  anti-angiogenic  activities  in  choroidal
neovascularization  [17].  In  line  with  this  notion,  we  also
observed  that  intraocularly  infiltrated  CX3CR1-positive
macrophages expressed anti-angiogenic molecules such as
thrombospondins and were protective against alkali-induced
CNV [18]. Thus, the monocyte/macrophage population may
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1614be heterogeneous in terms of angiogenic activities, which
depends on their chemokine receptor expression pattern.
We previously observed that CCR1 was expressed in
endothelial cells in human hepatoma tissue [19]. Furthermore,
both CCR1-knockout (KO) and CCL3-KO mice exhibited
impairment in carcinogen-induced hepatocarcinogenesis with
reduced  macrophage  infiltration  and  intra-tumor
neovascularization [20]. These observations would imply that
involvement of the CCL3-CCR1 axis in neovascularization is
essential. Because CCL3 can also bind to CCR5 as well as
CCR1 [21], we compared the molecular pathological changes
between WT mice and mice that were deficient in CCL3,
CCR1,  or  CCR5  in  a  frequently  used  ocular
neovascularization  model,  alkali-induced  CNV  [10,15,16,
18], to address the roles of CCL3 and its receptors in CNV.
We provided definitive evidence to indicate involvement of
the CCL3/CCR5 axis but not the CCL3/CCR1 axis in alkali-
induced CNV.
METHODS
Reagents and antibodies: Recombinant CCL3/MIP-1α (270-
LD) and goat anti-mouse CCL3 antibodies were obtained
from  R&D  Systems  (Minneapolis,  MN).  Rat  anti-mouse
F4/80 (clone A3–1) monoclonal antibody (mAb) was from
Serotec (Oxford, UK). Polyclonal rabbit antibody to CD31
(ab28364) was purchased from Abcam (Cambridge, UK). Rat
anti-mouse CD31 (MEC13.3), purified rat anti-mouse-Ly-6G
and Ly-6C (Gr-1) mAbs (clone RB6–8C5), and purified rat
anti-mouse CCR5 mAb (clone C34–3448) were purchased
from BD PharMingen (San Diego, CA). Goat anti-CCR1 pAb
(C-20) was obtained from Santa Cruz Biotechnology (Santa
Cruz, CA). Alexa Fluor (AF) 488 donkey anti-rat IgG (H+L),
AF594 donkey anti-rabbit IgG (H+L), and AF594 donkey anti-
goat IgG (H+L) were purchased from Invitrogen (Shanghai,
China).
Mice: CCL3-deficient (CCL3-KO) mice were obtained from
Jackson  Laboratories  (Bar  Harbor,  ME).  CCR1-deficient
(CCR1-KO)  and  CCR5-deficient  (CCR5-KO)  mice  were
generous gifts from Dr. P. M. Murphy and Dr. J. L. Gao
(NIADID,  NIH,  Bethesda,  MD)  [22]  and  from  Dr.  Kouji
Matsushima  (University  of  Tokyo,  Tokyo,  Japan),
respectively [23]. These deficient mice were backcrossed with
BALB/c  for  more  than  eight  generations.  Pathogen-free
BALB/c mice were obtained from Clea Japan (Yokohama,
Japan)  and  were  designated  as  WT  mice.  All  animal
experiments  were  performed  under  specific  pathogen-free
conditions  in  the  Institute  for  Experimental  Animals
(Kanazawa University, Kanazawa, Japan) in accordance with
the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research and complied with the standards set out
in the Guidelines for the Care and Use of Laboratory Animals
of Kanazawa University.
Alkali-induced  corneal  injury  model:  Corneal  injury  was
induced by placing a 2 mm filter disc saturated with 1 N NaOH
onto the left eye of the mouse as previously described [10,
18]. In some experiments, the alkali-treated eyes received
5  μl  of  CCL3  preparation  dissolved  in  0.2%  sodium
hyaluronate  (Sigma-Aldrich,  St.  Louis,  MO)  at  a
concentration of 3 μg/ml or 5 μl of 0.2% sodium hyaluronate
as the vehicle twice a day for seven days immediately after
the alkali injury. At the indicated time intervals, mice were
killed, and whole eyes were removed. The eyes were fixed in
10%  neutrally  buffered  formalin  or  were  snap  frozen  in
optimal  cutting  temperature  (OCT)  compound  (Sakura
Finetek,  Torrance,  CA).  In  some  mice,  the  corneas  were
removed from both eyes, placed immediately into RNALate
(Qiagen, Tokyo, Japan), and kept at −86 °C until total RNA
extraction was performed. Each experiment was repeated at
least three times.
Biomicroscopic examination: Eyes were examined under a
surgical  microsystem  (Lecia  MZ16;  Leica  Microsystems
GmbH, Wetzlar, Germany) 14 days after alkali injury by two
independent  observers  with  no  prior  knowledge  of  the
experimental procedures as described previously [10,18].
Histological  and  immunohistochemical  analysis:  The
paraffin-embedded tissues were cut into 5 µm thick slices and
were then subjected to hematoxylin and eosin staining. Other
sections  were  deparaffinized  with  xylene  and  rehydrated
through  graded  concentrations  of  ethanol  for
immunohistochemical  detection  of  F4/80  positive,  CCL3
positive, CCR1 positive, or CCR5 positive cells as described
previously [20]. The numbers of F4/80 positive cells were
counted at 200 fold magnification in five randomly chosen
fields of corneal sections from each animal [18,20] by an
examiner  with  no  prior  knowledge  of  the  experimental
procedures.  The  numbers  of  positive  cells/mm2  were
calculated.
A double-color immunofluorescence analysis: A double-color
immunofluorescence analysis was performed to determine the
cells  expressing  CCR5  and  CCR2.  Briefly,  the  fixed
cryosections  (8  µm  thick)  were  incubated  with  PBS
containing 1% normal donkey serum and 1% BSA to reduce
nonspecific reactions. Thereafter, the sections were incubated
with a combination of rat anti-CCR5 and rabbit anti-CCR2
overnight at 4 °C. After being rinsed with PBS, the sections
were then incubated with a combination of Alexa Fluor 488
donkey anti-rat IgG and Alexa Fluor 594 donkey anti-rabbit
IgG (1/100) for 40 min at room temperature in the dark.
Finally,  the  sections  were  washed  with  PBS,  and
immunofluorescence was visualized in dual-channel mode
with a fluorescence microscope (Olympus, Tokyo, Japan).
Images  were  processed  using  Adobe  Photoshop  software
version 7.0 (Adobe Systems, Tokyo, Japan).
Enumeration of corneal neovascularization: Deparaffinized
sections (5 µm thick) and fixed cryosections (8 µm thick) were
stained using rabbit anti-CD31 antibody (ab28364) [10] and
rat anti-CD31 antibody (MEC13.3) [18], respectively. The
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described [10] by an examiner with no prior knowledge of the
experimental procedures. Most sections were taken from the
central region of the cornea. The numbers and areas of corneal
neovascularization were evaluated on at least two sections
from each eye.
Semi-quantitative  reverse  transcription  polymerase  chain
reaction: Total RNAs were extracted from the corneas or
cultured  macrophages  with  the  use  of  RNeasy  Mini  Kit
(Qiagen, Tokyo, Japan), and the resultant RNA preparations
were  further  treated  with  RNase-free  DNase  I  (Life
Technologies Inc., Gaithersburg, MD) to remove genomic
DNA. Total RNA (2 μg) were reverse-transcribed at 42 °C for
1 h in 20 μl of reaction mixture containing mouse Moloney
leukemia  virus  reverse  transcriptase  and  hexanucleotide
random primers (Qiagen). cDNA (twofold serially diluted)
was amplified for β-actin (Table 1) to estimate the amount of
transcribed cDNA. Then, equal amounts of cDNA products
were amplified for the target genes using the primers under
the following conditions: denaturation at 94 °C for 2 min
followed by the optimal cycles of 30 s at 94 °C, 45 s at 53–
57 °C, 1 min at 72 °C, and a final 10 min extension step at
72 °C (Table 1). The amplified polymerase chain reaction
(PCR) products were fractionated on a 1.0% agarose gel and
visualized by ethidium bromide staining. The band intensities
were measured, and their ratios to β-actin were determined
with the aid of NIH Image Analysis software.
Murine  peritoneal  macrophages  isolation  and  culture:
Peritoneal  macrophages  were  obtained  as  described
previously [18]. The cells were suspended in antibiotic-free
RPMI medium containing 10% fetal bovine serum (FBS) and
incubated in a humidified incubator at 37 °C in 5% CO2 in 24
well  cell  culture  plates  (Nalge  Nunc  International  Corp.,
Naperville,  IL).  Two  hours  later,  non-adherent  cells  were
removed, and the medium was replaced. The cells were then
stimulated with the indicated concentrations of murine CCL3
for 12 h. Total RNAs were extracted from the cultured cells
and  subjected  to  reverse  transcription  polymerase  chain
reaction (RT–PCR) as described above. In another series of
experiments, murine macrophages were seeded onto 12 well
plates  at  5×105  cells/well.  After  adhesion,  the  cells  were
stimulated with the indicated concentrations of murine CCL3
for 24 h in a 37 °C incubator with 5% CO2. Supernatants were
collected to determine VEGF concentrations using a mouse
VEGF  ELISA  Kit  (R&D  Systems)  according  to  the
manufacturer’s instructions.
Statistical analysis: The means and the standard error of the
mean (SEM) were calculated for all parameters determined in
the study. Data were analyzed statistically using one-way
ANOVA or two-tailed Student’s t-test. A value of p<0.05 was
accepted as statistically significant.
RESULTS
Intracorneal expression of CCL3 and its receptor, CCR1 and
CCR5, after alkali-induced corneal injury: We first examined
the expression of CCL3, a ligand for CCR5 and CCR1, in
corneas after alkali-induced injury. CCL3 mRNA was barely
detectable in untreated eyes but was markedly increased after
alkali injury (Figure 1A). Concomitantly, CCL3 protein was
immunohistochemically  detected  in  epithelial  cells  and
infiltrating cells after alkali injury but not in untreated eyes
(Figure 1B). Moreover, alkali injury markedly augmented the
mRNA expression of specific receptors for CCL3, CCR1, and
CCR5  (Figure  1A).  Furthermore,  immunohistochemical
analysis demonstrated the infiltration of CCR1 expressing
leukocytes,  which  started  two  days  after  the  injury  and
increased thereafter (Figure 1B). These observations suggest
that alkali injury induced intracorneal production of CCL3,
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TABLE 1. SEQUENCES OF THE PRIMERS USED FOR REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION.
Gene
name Sequence
Product
    size
(bp)
 Annealing
temperature
(°C)
PCR
cycles
CCR1 F: TTTTAAGGCCCAGTGGGAGTT 475 57 37
R: TGGTATAGCCACATGCCTTT
CCR5 F:GTCCTCCTCCTGACCACCTT 122 55 38
R: GGGTTTAGGCAGCAGTGTGT
CCL3/MIP-α F: ATCATGAAGGTCTCCACCAC 284 56 37
R: TCTCAGGCATTCAGTTCCAG
VEGF F: CTGCTGTACCTCCACCATGCCAAGT 509 57 37
R: CTGCAAGTACGTTCGTTTAACTCA
bFGF F: CTTCCCACCAGGCCACTT 370 53 38
R: CTGTCCAGGTCCCGTTTT
TSP-1 F: ACCAAAGCCTGCAAGAAAGA 311 57 37
R: ATGCCATTTCCACTGTAGCC
β-actin F: TGTGATGGTGGGAATGGGTCAG 514 55 25
R: TTTGATGTCACGCACGATTTCC
All primers used were purchased from Genset Oligos (Kyoto, Japan). The amplification was performed using a GeneAmp®   PCR
System 9700 (Perkin-Elmer, Foster City, CA). In the table, "F" indicates forward primer and "R" indicates reverse primer.which in turn attracted CCR1 expressing or CCR5 expressing
leukocytes into the cornea.
Impaired  alkali-induced  corneal  neovascularization  in
CCL3-KO and CCR5-KO but not CCR1-KO, mice: We next
explored the effects of genetic ablation of CCL3, CCR1, and
CCR5 on alkali-induced CNV. CNV was macroscopically
evident in WT mice two weeks after the injury as we have
previously  reported  [10].  In  line  with  the  previous  report
[16], macroscopic CNV was markedly attenuated in CCR5-
KO  mice  (Figure  2A).  Moreover,  macroscopic  CNV  was
markedly reduced in CCL3-KO mice but in not CCR1-KO
mice (Figure 2A,B,C). Although corneas are physiologically
avascular, alkali injury markedly increased the vascular areas
in corneas of WT and CCR1-KO mice to similar extents, but
the increment was significantly reduced in CCL3-KO mice
(Figure 2B,C). These observations would indicate that the
CCL3-CCR5 axis was indispensable for alkali-induced CNV,
but the CCL3-CCR1 axis was not.
Reduced intraocular macrophage infiltration in CCL3-KO
but not CCR1-KO mice: We previously observed that Gr-1
positive  granulocytes  and  F4/80  positive  macrophages
infiltrated injured corneas, reaching their peak levels two to
four days after the injury in WT mice [10,18]. Leukocytes,
Figure 1. The expression of CCL3 and its receptors in cornea after
alkali injury. A: Semi-quantitative RT–PCR was performed to assess
mRNA expression of CCL3 and its receptors, CCR1 and CCR5, and
the ratios of target gene expression to β-actin were determined. All
values  represent  the  mean±SEM  of  three  to  five  independent
measurements. B: Whole eyes were obtained at 0, 2, 4, and 7 days
after alkali injury and processed for immunohistochemical analysis
using  anti-CCL3  (upper  panels)  or  anti-CCR1  antibodies  (lower
panels).  Representative  results  from  five  individual  animals  are
shown. Original magnifications, 400X. Scale bar, 50 μm.
Figure  2.  Alkali-induced  corneal  neovascularization  and
macrophage infiltration. A: The macroscopic appearances of WT,
CCL3-KO, CCR1-KO, and CCR5-KO mouse eyes two weeks after
alkali injury are illustrated. Representative results from at least 10
animals in each group are shown here. B: Corneal tissues were
obtained from WT, CCR1-KO, and CCL3-KO mice two weeks after
the injury. Tissues were stained with hematoxylin and eosin (left
panels) or immunostained with anti-CD31 antibodies (right panels),
and representative results from five individual animals are shown.
Original magnifications, 400X. Scale bar, 50 μm. C: CNV numbers
per mm2 in hot spots (upper panel) and % CNV areas in hot spots
(lower panel) were determined on corneas obtained from WT or KO
mice two weeks after the injury. Each value represents the mean and
SEM (n=5 animals). An asterisk represents a p<0.05 and that the
value was obtained comparing WT and CCL3-KO mice. D: The
numbers of infiltrated F4/80 positive macrophages were determined
two and four days after the injury. Each value represents the mean
and SEM (n=5). The double asterisk indicates a p<0.01 and that the
value was obtained comparing WT and CCL3-KO mice.
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particularly monocytes/macrophages, can be a rich source ofangiogenic factors [24-28]. Given the fact that CCL3 recruit
macrophages, which express CCR1 and CCR5, we examined
the effects of CCL3 deficiency on leukocyte infiltration into
the wounded cornea. Neither F4/80 positive macrophages nor
Gr-1 positive granulocytes were present in untreated corneas
of  WT  and  CCL3-KO  mice.  Gr-1  positive  granulocytes
infiltrated to similar extents into the corneas of both WT and
CCL3-KO mice after the injury (data not shown). In contrast,
F4/80 positive macrophage infiltration was markedly reduced
in CCL3-KO mice but not in CCR1-KO mice when compared
with  WT  mice  (Figure  2D).  Thus,  CCL3  may  regulate
intraocular infiltration of F4/80 positive macrophages but not
Gr-1 positive granulocytes.
Reduced vascular endothelial growth factor expression in
CCL3-KO  mice  after  alkali  injury:  The  balance  between
angiogenic  and  anti-angiogenic  factors  can  determine  the
outcome  of  angiogenetic  processes  in  various  situations.
Hence, we examined the mRNA expression of angiogenic and
anti-angiogenic  factors  in  corneas  after  the  injury.  Alkali
injury  increased  intraocular  mRNA  expression  of  an
angiogenic factor, basic fibroblast growth factor (bFGF), and
an anti-angiogenic molecule, thrombospondin (TSP-1), in WT
and  CCL3-KO  mice  to  similar  extents  (Figure  3A).  In
contrast,  mRNA  expression  of  another  potent  angiogenic
factor, VEGF, was markedly augmented in WT mice, and the
increase was markedly attenuated in CCL3-KO mice (Figure
3A).
Enhanced vascular endothelial growth factor expression by
murine peritoneal macrophages with CCL3 stimulation: We
next  examined  the  effects  of  exogenous  CCL3  on  VEGF
expression by mouse peritoneal macrophages at the mRNA
and  protein  levels.  CCL3  markedly  enhanced  the  mRNA
expression of VEGF by peritoneal macrophages (Figure 3B).
Concomitantly, CCL3 increased VEGF protein production by
macrophages in a dose-dependent manner (Figure 3C). These
observations  would  indicate  that  CCL3  can  activate
macrophages to produce an angiogenic factor, VEGF.
Simultaneous CCR2 expression by intracorneally infiltrating
CCR5  expressing  cells:  We  previously  revealed  that  the
CCL2/CCR2  interactions  could  induce  VEGF  expression
[18].  Hence,  we  next  examined  whether  intraocularly
infiltrating CCR5 expressing cells also expressed CCR2. A
double-color immunofluorescence analysis demonstrated that
CCR5 expressing cells also expressed CCR2 (Figure 4A).
Moreover,  alkali  injury-induced  increases  in  intracorneal
CCR5 positive cell numbers were attenuated in CCL3-KO
mice (Figures 4B,C). Thus, it is likely that CCL3 can regulate
intraocular  infiltration  of  CCR5  expressing  macrophages,
which can express VEGF by the CCL2/CCR interactions.
Restoration of alkali-induced corneal neovascularization in
CCL3-KO mice by topical CCL3 application: Finally, we
examined the effects of topical CCL3 application on alkali-
induced CNV of CCL3-KO mice. CCL3-KO mice exhibited
reduced  alkali-induced  CNV  at  both  macroscopic  and
microscopic levels compared with WT mice (Figure 5A-C).
Topical CCL3 application restored CNV to an extent similar
to that seen in WT mice (Figure 5A-C). Concomitantly, CCL3
treatment reversed the macrophage infiltration in CCL3-KO
mice to similar levels as WT mice (Figure 5D). Thus, CCL3
may induce the infiltration of macrophages, which in turn may
produce a potent angiogenic factor, VEGF, and eventually
promote alkali-induced CNV.
DISCUSSION
Tissue  injury  induced  the  expression  of  various  growth
factors, cytokines, and chemokines, which all contribute to
tissue repair in a coordinated manner [29]. In cooperation with
adhesion molecules, chemokines can regulate the trafficking
of various types of leukocytes, which in turn regulate two
processes of tissue repair, granulation tissue formation, and
neovascularization by producing various growth factors and
cytokines [29-32]. Moreover, several chemokines can directly
regulate  neovascularization  [33].  Alkali  injury  induced  a
Figure 3. Angiogenic factor expression. A: RT–PCR analysis of pro-
angiogenic  and  anti-angiogenic  gene  expressions  in  the  injured
corneas  of  WT  and  CCL3-KO  mice.  RT–PCR  analysis  was
performed on total RNAs extracted from eyes 0, 2, 4, and 7 days after
alkali injury, and then the ratios of VEGF to β-actin, bFGF to β-actin,
and TSP-1 to β-actin of WT (black bars) and CCL3-KO mice (open
bars) were determined. All values represent the mean and SEM
(n=3-5  animals).  The  asterisk  denotes  a  p<0.05;  the  hash  mark
denotes a p<0.01 and that the value was obtained comparing WT and
KO mice. The effects of CCL3 on VEGF expression by murine
peritoneal macrophages is shown in B and C. B: RT–PCR was
performed  on  macrophages  incubated  with  the  indicated
concentrations of CCL3 for 12 h, and the ratio of VEGF to β-actin
was calculated. Each value represents the mean and SEM (n=3). C:
Murine macrophages were stimulated with either 0, 10, or 100 ng/
ml of CCL3 for 24 h. VEGF concentrations in the supernatants were
determined with ELISA as described in Methods. The representative
results from three independent experiments are shown. The asterisk
denotes a p<0.05 and the double asterisk denotes a p<0.01 when
compared to untreated.
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intraocular  CCL3  expression.  Several  independent  groups
reported that CCL3 has direct effects on endothelial cells
[33] and that its receptor, CCR1, was expressed in certain
types of endothelial cells [19,20]. However, CCL3 can restore
CNV in CCL3-KO mice to similar levels shown in WT mice.
This  restoration  of  CNV  is  seen  even  if  CCL3  was
administered only in the early phase after the injury at the time
when the endothelial cells are absent. Thus, CCL3 may not
directly target endothelial cells in this model.
The cornea lacks vasculature under normal physiologic
conditions. Corneal avascularity is maintained by the balance
between angiogenic factors including VEGF and bFGF and
anti-angiogenic factors including TSP-1 and soluble VEGF
receptor I [1,2]. Alkali injury augmented intraocular mRNA
expression of bFGF and TSP-1 in CCL3-KO mice to an extent
similar to that in WT mice. On the contrary, alkali-induced,
enhanced  VEGF  expression  was  markedly  attenuated  in
CCL3-KO mice. Because soluble VEGF receptor I, a decoy
receptor for VEGF, is constitutively present and acts as a
Figure 4. Intracorneal CCR5 positive cell infiltration. A: A double-
color  immunofluorescence  analysis  of  CCR5-expressing  cells  is
illustrated. Corneas were obtained from WT mice 0 and 4 days after
the injury. The samples were immunostained with a combination of
anti-CCR5 and anti-CCR2 antibodies as described in Methods and
observed  with  fluorescence  microscopy  (original  magnification,
400X). Signals were digitally merged in the right panels. Arrows
indicate the double, positively stained cells. Representative results
from three independent experiments are shown. B: Corneal tissues
from WT mice (left panel) or CCL3-KO mice (right panel) obtained
four days after the injury were stained with anti-CCR5 Ab. Scale bar,
100 μm. C: The numbers of intracorneal CCR5 positive cells four
days after the injury were determined as described in Methods, and
the mean and SEM are shown here (n=5).
major anti-angiogenic factor in the cornea [1], the reduced
VEGF  expression  in  CCL3-KO  mice  may  account  for
attenuated CNV after alkali injury in these mice. Moreover,
CCL3 can augment VEGF production by macrophages. Thus,
it is likely that CCL3 induced CNV indirectly by inducing the
infiltration and activation of macrophages, a major source of
VEGF.
Macrophages are proposed to play crucial roles in tissue
repair  based  on  the  observations  that  these  cells  can
abundantly produce various growth and angiogenic factors.
As  seen  with  other  types  of  leukocytes,  macrophage
infiltration  is  regulated  mainly  by  coordinated  actions  of
adhesion molecules and chemokines. Chemokines bind to
their cognate receptors on leukocytes to exert their actions.
Macrophages express a limited set of chemokine receptors
including CCR1, CCR2, CCR5, and CX3CR1 and exhibit
chemotaxis to their ligands [12-14]. CCL3 utilizes two distinct
Figure  5.  The  effects  of  topical  CCL3  application  on  corneal
neovascularization. A: Macroscopic appearances of WT, CCL3-KO
mice, and CCL3-KO mice topically applied with CCL3 two weeks
after  alkali  injury  are  shown.   Representative  results   from   five
animals from each group are shown here. B: Corneal tissues were
obtained two weeks after the injury from WT, CCL3-KO, and CCL3-
KO mice topically applied with CCL3 and were immunostained with
anti-CD31 antibodies. Representative results from five individual
mice from each group are shown. Original magnification, 400X.
Scale bar, 50 μm. C: The CNV numbers per mm2 in hot spots (left
panel) and % CNV areas in hot spots (right panel) were determined.
Each value represents the mean and SEM (n=5 animals). D: The
number of infiltrated F4/80 positive macrophages was determined
on WT, CCL3-KO, and CCL3-KO, which were all treated with
CCL3, two days after the injury. Each value mean represents both
the mean and SEM (n=5). The asterisk denotes a p<0.05, and the
double asterisk means a p<0.01 when compared with CCL3-KO (this
applies to both C and D).
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their expression patterns [12,21]. Reduced CNV in CCR5-KO
mice prompted us to evaluate the roles of CCL3 and CCR1 in
this  model.  CCL3  deficiency  but  not  CCR1  deficiency
reduced  alkali-induced  CNV.  We  recently  observed  that
bleomycin-induced  intrapulmonary  macrophage
accumulation  and  subsequent  pulmonary  fibrosis  was
attenuated in CCL3-KO and CCR5-KO mice but not in CCR1
KO mice [34]. This suggests that CCR5 expressing cells are
distinct from CCR1 expressing cells. Indeed, a double-color
immunofluorescence  analysis  demonstrated  that  CCR5
expressing  cells  did  not  express  CCR1  simultaneously
(unpublished  data).  Thus,  CCL3  may  generally  regulate
macrophage functions by binding CCR5 expressed on their
surface but not CCR1.
A partial reduction of macrophage infiltration by CCL3
deficiency suggests a contribution of other chemokines such
as CCL2 and CX3CL1 to macrophage infiltration. This may
further indicate heterogeneity of monocytes/macrophages in
terms of chemokine receptor expression patterns as previously
suggested by Geissmann and colleagues [35] who proposed
the  presence  of  two  blood  monocytes  consisting  of
inflammatory  CX3CR1lowCCR2+  and  resting
CX3CR1highCCR2- populations. Macrophages are presumed
to  exert  pro-angiogenic  actions  under  various  situations
[24-28],  but  Apte  and  colleagues  [17]  demonstrated  anti-
angiogenic  activities  of  macrophages  in  CNV.  These
observations  suggest  a  functional  heterogeneity  among
macrophages during the angiogenetic process. Indeed, we
demonstrated  that  CX3CR1  positive  macrophages  could
dampen alkali-induced CNV by producing anti-angiogenic
molecules [18], which is in contrast to the observations on
CCR2-deficient mice [15]. We previously revealed that the
CCL2/CCR2 interactions were involved in VEGF production
[18] and observed that CCR5 expressing cells simultaneously
expressed CCR2. Thus, CCR5 deletion reduced the number
of CCR2 expressing macrophages, the cells that can express
VEGF, and as a result, this reduction eventually prevented
alkali-induced CNV.
Several independent groups have reported the presence
of resident macrophages, dendritic cells, langerhans cells, and
T cells in normal corneas [36-39]. The number of resident
macrophages in the normal corneal stroma is around 100 per
mm2 [36], and in the current experimental conditions, we
detected  few,  if  any,  F4/80  positive  or  CD68  positive
macrophages in the normal corneas [18]. Thus, it is not likely
that corneal resident macrophages contribute directly to CNV.
However,  the  simple  dichotomy  of  monocytes/
macrophages proposed by Geissmann was complicated by the
observation that CCR2- and CCR2+ monocytes depended on
CCR5 and CX3CR1, respectively, when they entered into
atherosclerotic  plaques  [40].  Ambati  and  colleagues  [15]
reported that CCR2 deficiency inhibited CNV, but they did
not examine the roles of macrophages in this process. Thus,
the effects of the CCR2 axis on macrophage infiltration in
CNV or the interaction between the CCR2 and CCR5 axis
remain  unclear.  More  detailed  analysis  on  this  point  will
clarify  the  molecular  and  cellular  mechanisms  underlying
macrophage infiltration and subsequent CNV development.
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